Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study

[1]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[2]  P A Poole-Wilson,et al.  The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. , 2004, American heart journal.

[3]  N. Freemantle,et al.  Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure , 2004, European journal of heart failure.

[4]  M. Guazzi,et al.  Aspirin–Angiotensin-Converting Enzyme Inhibitor Coadministration and Mortality in Patients With Heart Failure: A Dose-Related Adverse Effect of Aspirin , 2003 .

[5]  R. Collins,et al.  Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review , 2002, The Lancet.

[6]  L. Lipsitz,et al.  Does Aspirin Attenuate the Effect of Angiotensin‐Converting Enzyme Inhibitors on Health Outcomes of Very Old Patients with Heart Failure? , 2002, Journal of the American Geriatrics Society.

[7]  S. Geraci,et al.  Anticoagulation in patients with dilated cardiomyopathy and sinus rhythm: a critical literature review. , 2002, Journal of cardiac failure.

[8]  J. Cleland.  Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease. , 2002, Progress in cardiovascular diseases.

[9]  P. Toutouzas,et al.  Antithrombotic therapy in heart failure: a randomized comparison of warfarin vs. aspirin (HELAS) , 1999, European journal of heart failure.

[10]  W. Rand,et al.  Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.

[11]  J. Cleland.  Anticoagulant and antiplatelet therapy in heart failure. , 1997, Current opinion in cardiology.

[12]  M. Domanski,et al.  Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. , 1997, Journal of the American College of Cardiology.

[13]  G. Lamas,et al.  Ventricular dysfunction and the risk of stroke after myocardial infarction. , 1997, The New England journal of medicine.

[14]  L. Tavazzi,et al.  Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients. , 1996, European heart journal.

[15]  R. Falk,et al.  Is aspirin safe for patients with heart failure? , 1995, British heart journal.

[16]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[17]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.